May 20, 2019 / 07:00PM GMT
Carter Lewis Gould - UBS Investment Bank, Research Division - Large Cap Biotech Analyst
Okay. Good afternoon. My name is Carter Gould. I'm a senior biotech analyst here at UBS. Welcome to day 1 of the Global Healthcare Conference. I'm pleased to welcome Incyte to the stage. CEO and President, Hervé Hoppenot, is joining me. I also remind everyone if you'd like to ask questions through the app, please feel free. They will filter down to the iPad here and I will try to ask them. All right. Thank you very much for joining us.
HervéHoppenot - Incyte Corporation - Chairman, President & CEO
Thank you for inviting me.
Carter Lewis Gould - UBS Investment Bank, Research Division - Large Cap Biotech Analyst
I don't know if you want to make some opening statements or you just begin to...
HervéHoppenot - Incyte Corporation - Chairman, President & CEO
I could. Yes, if it's helpful -- I mean basically, the situation for Incyte today is based on
Incyte Corp at UBS Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot